Torrent Pharmaceuticals Limited — Board Meeting, 20-05-2025: Outcome of Board Meeting

Torrent Pharmaceuticals has announced a board meeting on the audited consolidated financial results for the quarter and year ended March 31, 2025. Revenue rose 7% YoY to Rs 11,516 Cr, with net profit up 15%, excluding litigation-related items, at Rs 1,911 Cr. India led growth at 13%, driven by chronic therapies, while the US and Germany showed moderate gains. Brazil revenue fell 2% due to currency effects but grew 9% on a constant currency basis. R&D spend was Rs 581 Cr (5% of sales). A final dividend of Rs 6/share is proposed. Aman Mehta will become Managing Director from August 1, 2025.